UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comprehensive review of JAK inhibitors in myeloproliferative neoplasms

Therapeutic advances in hematology, 2013-02, Vol.4 (1), p.15-35

2013

Volltextzugriff (PDF)

Phase II Clinical Trial of Gefitinib for the Treatment of Chemonaïve Patients with Advanced Non-small Cell Lung Cancer with Poor Performance Status

Clinical Medicine Insights. Oncology, 2014-01, Vol.2014 (8), p.121-128

2014

Volltextzugriff (PDF)

Effect of a Neutropenic Diet on Infection and Mortality Rates in Cancer Patients: A Meta-Analysis

Nutrition and cancer, 2015-11, Vol.67 (8), p.1232-1240

2015

Volltextzugriff (PDF)

The Use of Pharmacogenomics for Selection of Therapy in Non-Small-Cell Lung Cancer

Clinical Medicine Insights. Oncology, 2014-01, Vol.2014 (8), p.139-144

2014

Volltextzugriff (PDF)

Evaluating the clinical, environmental, genetic, and genomic profile of men with early-onset aggressive prostate cancer (PCa)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e17517-e17517

2020

Volltextzugriff (PDF)

Evaluating the clinical, environmental, genetic, and genomic profile of men with early-onset aggressive prostate cancer (PCa)

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.TPS333-TPS333

2019

Volltextzugriff (PDF)

Tyrosine kinase inhibitors as a first‐line treatment in patients with newly diagnosed chronic myeloid leukemia in chronic phase: A mixed‐treatment comparison

International journal of cancer, 2016-03, Vol.138 (6), p.1545-1553

2016

Volltextzugriff (PDF)

Detection of EGFRvIII mutant DNA in the peripheral blood of brain tumor patients

Journal of neuro-oncology, 2013-10, Vol.115 (1), p.27-35

2013

Volltextzugriff (PDF)

ROS1 amplification mediates resistance to gefitinib in glioblastoma cells

Oncotarget, 2015-08, Vol.6 (24), p.20388-20395

2015

Volltextzugriff (PDF)

Adverse Effects of Androgen Deprivation in Elderly Men with Prostate Cancer

Current geriatrics reports, 2019-12, Vol.8 (4), p.315-321

2019

Volltextzugriff (PDF)

Burden of Disease and Clinical Responses in Low and Intermediate-1 Risk Myelofibrosis Patients Treated with Ruxolitinib

Blood, 2014-12, Vol.124 (21), p.1834-1834

2014

Volltextzugriff (PDF)

The Complexity of Interpreting Genomic Data in Patients with Primary and Secondary Acute Myeloid Leukemia (AML)

Blood, 2015-12, Vol.126 (23), p.86-86

2015

Volltextzugriff (PDF)

Outcome of Newly Diagnosed Acute Myeloid Leukemia (AML) Refractory to 1 or 2 Cycles of Induction Chemotherapy

Blood, 2015-12, Vol.126 (23), p.1319-1319

2015

Volltextzugriff (PDF)

Prolonged Survival in a Patient with Metastatic Vasoactive Intestinal Peptide Producing Pancreatic Neuroendocrine Tumors

Journal of clinical case reports, 2012, Vol.2 (15)

Ahmad Zarzour, Nagla Karim

2012

Volltextzugriff (PDF)

Incorporation of Molecular Data into the Current Prognostic Models in Treated Patients with Myelodysplastic Syndromes: Which Model Is the Best

Blood, 2016-12, Vol.128 (22), p.50-50

2016

Volltextzugriff (PDF)

Impact of Non-JAK2 Molecular Mutations and Cryptic SNP Lesions in Myelofibrosis Patients Treated with Ruxolitinib

Blood, 2014-12, Vol.124 (21), p.3194-3194

2014

Volltextzugriff (PDF)

Rates of Infection in Myelofibrosis Patients Treated with Ruxolitinib

Blood, 2014-12, Vol.124 (21), p.1835-1835

2014

Volltextzugriff (PDF)

The Impact of Different TP53 Mutations on Outcome in Patients with Myelodysplastic Syndromes (MDS)

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.S45-S45

2015

Volltextzugriff (PDF)

The Use of Pharmacogenomics for Selection of Therapy in Non-Small-Cell Lung Cancer

Clinical Medicine Insights. Oncology, 2014-12, Vol.2014 (8), p.139-144

2014

Volltextzugriff (PDF)

Phase II Clinical Trial of Gefitinib for the Treatment of Chemonaïve Patients with Advanced Non-small Cell Lung Cancer with Poor Performance Status

Clinical Medicine Insights. Oncology, 2014-01, Vol.8

2014

Volltextzugriff (PDF)

A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet

Molecules (Basel, Switzerland), 2022-01, Vol.27 (3), p.858

2022

Volltextzugriff (PDF)

A comparative study of transradial versus transfemoral approach for flow diversion

Neuroradiology, 2021-08, Vol.63 (8), p.1335-1343

2021

Volltextzugriff (PDF)

Cardiovascular Impact of Calcium and Vitamin D Supplements: A Narrative Review

Endocrinology and metabolism (Seoul), 2023-02, Vol.38 (1), p.56-68

2023

Volltextzugriff (PDF)

Phyllanthus Niruri Standardized Extract Alleviates the Progression of Non-Alcoholic Fatty Liver Disease and Decreases Atherosclerotic Risk in Sprague-Dawley Rats

Nutrients, 2017-07, Vol.9 (7), p.766

2017

Volltextzugriff (PDF)

Adipocytokine Regulation and Antiangiogenic Activity Underlie the Molecular Mechanisms of Therapeutic Effects of Phyllanthus niruri against Non-Alcoholic Fatty Liver Disease

Nutrients, 2018-08, Vol.10 (8), p.1057

2018

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(66)

Sprache

Englisch
(65)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comprehensive review of JAK inhibitors in myeloproliferative neoplasms

Phase II Clinical Trial of Gefitinib for the Treatment of Chemonaïve Patients with Advanced Non-small Cell Lung Cancer with Poor Performance Status

Effect of a Neutropenic Diet on Infection and Mortality Rates in Cancer Patients: A Meta-Analysis

The Use of Pharmacogenomics for Selection of Therapy in Non-Small-Cell Lung Cancer

Evaluating the clinical, environmental, genetic, and genomic profile of men with early-onset aggressive prostate cancer (PCa)

Evaluating the clinical, environmental, genetic, and genomic profile of men with early-onset aggressive prostate cancer (PCa)

Tyrosine kinase inhibitors as a first‐line treatment in patients with newly diagnosed chronic myeloid leukemia in chronic phase: A mixed‐treatment comparison

Detection of EGFRvIII mutant DNA in the peripheral blood of brain tumor patients

ROS1 amplification mediates resistance to gefitinib in glioblastoma cells

Adverse Effects of Androgen Deprivation in Elderly Men with Prostate Cancer

Burden of Disease and Clinical Responses in Low and Intermediate-1 Risk Myelofibrosis Patients Treated with Ruxolitinib

The Complexity of Interpreting Genomic Data in Patients with Primary and Secondary Acute Myeloid Leukemia (AML)

Outcome of Newly Diagnosed Acute Myeloid Leukemia (AML) Refractory to 1 or 2 Cycles of Induction Chemotherapy

Prolonged Survival in a Patient with Metastatic Vasoactive Intestinal Peptide Producing Pancreatic Neuroendocrine Tumors

Incorporation of Molecular Data into the Current Prognostic Models in Treated Patients with Myelodysplastic Syndromes: Which Model Is the Best

Impact of Non-JAK2 Molecular Mutations and Cryptic SNP Lesions in Myelofibrosis Patients Treated with Ruxolitinib

Rates of Infection in Myelofibrosis Patients Treated with Ruxolitinib

The Impact of Different TP53 Mutations on Outcome in Patients with Myelodysplastic Syndromes (MDS)

The Use of Pharmacogenomics for Selection of Therapy in Non-Small-Cell Lung Cancer

Phase II Clinical Trial of Gefitinib for the Treatment of Chemonaïve Patients with Advanced Non-small Cell Lung Cancer with Poor Performance Status

A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet

A comparative study of transradial versus transfemoral approach for flow diversion

Cardiovascular Impact of Calcium and Vitamin D Supplements: A Narrative Review

Phyllanthus Niruri Standardized Extract Alleviates the Progression of Non-Alcoholic Fatty Liver Disease and Decreases Atherosclerotic Risk in Sprague-Dawley Rats

Adipocytokine Regulation and Antiangiogenic Activity Underlie the Molecular Mechanisms of Therapeutic Effects of Phyllanthus niruri against Non-Alcoholic Fatty Liver Disease

Suchergebnisse filtern